Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Century Therapeutics (IPSC) Interest Expenses (2022 - 2023)

Historic Interest Expenses for Century Therapeutics (IPSC) over the last 2 years, with Q2 2023 value amounting to $136000.0.

  • Century Therapeutics' Interest Expenses fell 5878.79% to $136000.0 in Q2 2023 from the same period last year, while for Mar 2024 it was $136000.0, marking a year-over-year decrease of 9105.26%. This contributed to the annual value of $540000.0 for FY2023, which is 6223.78% down from last year.
  • Per Century Therapeutics' latest filing, its Interest Expenses stood at $136000.0 for Q2 2023, which was down 5878.79% from $404000.0 recorded in Q1 2023.
  • In the past 5 years, Century Therapeutics' Interest Expenses registered a high of $413000.0 during Q4 2022, and its lowest value of $136000.0 during Q2 2023.